AGM/EGMApr 30, 2026, 04:19 PM
MIST 2026 Annual Meeting on June 10; Equity Plan Vote
AI Summary
Milestone Pharmaceuticals Inc. announced its 2026 Annual Meeting of Shareholders will be held virtually on June 10, 2026. Shareholders will vote on the election of eight directors, ratification of PwC as auditor, approval to increase shares for the 2019 Equity Incentive Plan by 6,800,000, and a non-binding advisory vote on executive compensation. The record date for voting is April 15, 2026, with 119,637,391 common shares outstanding.
Key Highlights
- Annual Meeting of Shareholders scheduled for June 10, 2026, at 11:00 a.m. ET.
- Shareholders to vote on the election of eight director nominees.
- Proposal to ratify PricewaterhouseCoopers LLP as the auditor.
- Approval sought to increase shares for 2019 Equity Incentive Plan by 6,800,000.
- Non-binding advisory vote on named executive officer compensation.
- Record date for voting is April 15, 2026.
- Voting deadline for proxies is June 8, 2026, at 5:00 p.m. ET.
- 119,637,391 common shares outstanding and entitled to vote as of record date.
Price Impact
More from MIST